According to #TechSci Research report, United States Diagnostics Market stood at USD30.08billion in 2020 and is expected to grow at a steady rate of 5.17% during the forecast period. Gain More Insight: https://bit.ly/3wWI0do Get Sample Report: https://bit.ly/3ltFdo6 Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/

1. 1
©
TechSci
Research
United States Diagnostics Market
FORECAST AND OPPORTUNITIES
2016 – 2026
PUBLISHED: MAY 2021
M A R K E T I N T E L L I G E N C E . C O N S U L T I N G www.techsciresearch.com

2. 2
© TechSci Research
Table of Contents
S. No. Contents
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on United States Diagnostics Market
4. Executive Summary
5. Voice of Customer
5.1. Brand Awareness
5.2. Reasons for Getting Diagnostic Test Done
5.3. Preferred Choice of Setup for Diagnostic Test
6. United States Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Reagents, Instruments, Software & Services)
6.2.2.
By Type of Test (Infectious Disease Testing, Lipid Panel Test, Metabolic Panel Test,
Others)
6.2.3.
By Technique (Immunodiagnostics, Clinical Techniques, Molecular Diagnostics,
Tissue Diagnostics, Others)
6.2.4. By Usability (Reusable v/s Disposable)
6.2.5.
By Application (Infectious Diseases {Human Papillomavirus, Hepatitis, Tuberculosis,
Hospital-Acquired Infections, COVID-19}, Cancer {Breast Cancer, Lung Cancer,
Colorectal Cancer, Melanoma, Liver Cancer, Others}, Sexually Transmitted Diseases
{Chlamydia Trachomatis Infection, Gonorrhoea, Syphilis, Others}, Others)
6.2.6.
By End User (Hospitals, Public Labs, Diagnostic Centers, Point-of-care Testing
Centers, Private or Commercial Laboratories, Others)

3. 3
© TechSci Research
Table of Contents
S. No. Contents
6.2.7 By Region (South; West; Mid-West; and North-East)
6.2.8. By Company (2020)
6.2.9. Company-Wise List of Major Diagnostics Kits Approved
6.3. Market Map (By Product Type, By Type of Test, By Technique, By Usability)
7. United States Infectious Disease Testing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Technique
7.2.3. By Usability
7.2.4. By Application
7.2.5. By End User
7.2.6. By Region
8. United States Lipid Panel Test Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Technique
8.2.3. By Usability
8.2.4. By Application
8.2.5. By End User

4. 4
© TechSci Research
Table of Contents
S. No. Contents
8.2.6. By Region
9. United States Metabolic Panel Test Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Technique
9.2.3. By Usability
9.2.4. By Application
9.2.5. By End User
9.2.6. By Region
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends and Developments
12. Policy and Regulatory Landscape
13. United States Economic Profile
14. Competitive Landscape
14.1. Competition Outlook
14.2. Company Profiles
14.2.1. Abbott Laboratories, Inc.
14.2.2. Danaher Corporation
14.2.3. Thermo Fischer Scientific, Inc.

5. 5
© TechSci Research
Table of Contents
S. No. Contents
14.2.4. Johnson & Johnson
14.2.5. Ortho-Clinical Diagnostics, Inc.
14.2.6. Becton, Dickinson and Company
14.2.7. Bio-Rad Laboratories, Inc.
14.2.8. Roche Diagnostics Corporation
14.2.9. Siemens Medical Solutions USA, Inc.
14.2.10. Biomerieux Inc.
15. Strategic Recommendations
16. About Us & Disclaimer

6. PRODUCT OVERVIEW

7. 7
© TechSci Research
Scope of Report
Product of Interest (POI): Diagnostics
Review Period
2016 – 2019
Base Year
2020
Estimated Year
2021
Forecast Period
2022 – 2026
Year Range
Diagnostics include various practices or techniques used for different diseases or conditions which
explain a patient’s symptoms and signs. There are many tests or procedures used to diagnose the
prevalence and severity of various diseases or ailments. All these tests or procedures performed for
the identification and treatment of different diseases or conditions are part of diagnostics.
Diagnostic tests and procedures help in early diagnosis of diseases so that the treatment can be
provided on time. Additionally, diagnostic procedures are helpful once a patient suffers from a
certain disease to identify the stage of the disease whether it is acute or chronic. This in turn helps
the physicians/doctors to provide appropriate treatment to their patients and also patients become
aware about the severity of their disease.
Market Segmentation
BY PRODUCT TYPE
• Reagents
• Instruments
• Software & Services
BY TYPE OF TEST
• Infectious Disease Testing
• Lipid Panel Test
• Metabolic Panel Test
• Others
BY TECHNIQUE
• Immunodiagnostics
• Clinical Techniques
• Molecular Diagnostics
• Tissue Diagnostics
• Others
BY USABILITY
• Reusable
• Disposable
BY APPLICATION
• Infectious Diseases
• Cancer
• Sexually Transmitted
Diseases
• Others
BY END USER
• Hospitals
• Public Labs
• Diagnostic Centers
• Point-of-Care Testing
Centers
• Private or Commercial
Laboratories
• Others
BY REGION
• South
• Mid-West
• West
• North-East

8. RESEARCH METHODOLOGY

9. 9
© TechSci Research
Research Methodology
A
C
B
Primary
Research
Company
Analysis
Desk
Research
 Identifying Key Opinion
Leaders
 Questionnaire Design
 In-depth Interviews
 Market Participants
 Key Strengths
 Recent
Developments
 Market Changing
Aspects/Dynamics
 Government
Policies
 Final Conclusion
 LinkedIn
 TechSci Internal
Database
 Factiva
 Hoovers
Paid Sources
 Company Websites
 Company Annual
Reports
 White Paper Study
 Financial Reports
 Investor
Presentations
 Regulatory Body,
Associations, etc.
Secondary
Research
Primary
Research
Data
Collection
Data Filter
& Analysis
Research &
Intelligence
Actionable
Insights
Business
Solution
•In-depth secondary research was conducted to
identify players in United States diagnostics
market, overall market size and segmental
market size.
Market Profiling
•In order to conduct interviews with industry
experts, TechSci Research formulated a detailed
questionnaire.
Formulating Questionnaire
•List of industry players and industry specialists
was developed.
Developing List of Respondents
•TechSci conducted interviews with industry
experts and industry players for data collection
and verification.
Data Collection
•Data obtained as a result of primary and
secondary research was validated through
rigorous triangulation.
Data Validation
•The data was scrutinized using MS-Excel and
statistical tools, such as Time Series Analysis,
etc., to obtain qualitative and quantitative
insights about United States Diagnostics market.
Data Analysis

10. 10
© TechSci Research
Primary
Research
80%
Desk Research
20%
Research Contribution
Telephonic
Survey
85%
Online Survey
15%
Survey Mode
Product/
Stakeholders
Service Providers Distributors/Dealers Industry Experts Total
Diagnostics 30–40 100-150 20-25 200+
For executing the study, TechSci Research used bottom-up model, which was later on cross validated by using top-down
approach. TechSci Research followed a mix of exhaustive secondary research and primary research for this study.
Phase 1: Initially, TechSci Research would try to source the list of diagnostics service providers worldwide. Then, primary
research surveys will be conducted with the identified companies, and they will also be asked for their other competitors
in the market. By this way if we may have missed any target company due to limitations of secondary research then we
will be able to identify that company and then survey them as well.
Below mentioned is the tentative number of surveys that were conducted during the study:
Research Methodology

11. 11
© TechSci Research
Research Methodology
Phase 2: For the study, TechSci Research has gathered information through primary research surveys with leading
diagnostic companies of various regions across the United States, and subsequently, verified information from
prominent companies engaged in the diagnostics market, worldwide. Exhaustive search of credible paid databases
such as Factiva, Hoovers, etc., including our internal database. Our team of analysts has then prudently evaluated all
the collected information and presented the same in a chronological order to depict a meaningful and clear picture of
United States diagnostics market. While compiling the data, we have also cross checked all the collected information
from multiple sources and data warehouses, to present the most accurate and precise information of the concerned
industry.
Primary Research – Prominent Companies &
Associations Interviewed
S. No. Company Name
1 Abbott Laboratories, Inc.
2 Danaher Corporation
3 Thermo Fisher Scientific, Inc.
4 Johnson & Johnson
5 Ortho-Clinical Diagnostics, Inc.
6 Becton, Dickinson, and Company
7 Bio-Rad Laboratories, Inc.
8 Roche Diagnostics Corporation
9 Siemens Medical Solutions USA, Inc.
10 Biomerieux Inc.
Some Sources of Secondary Research
S. No. Secondary Source
1 World Bank
2
TechSci Research Proprietary Database &
Knowledge Repository
3 Company Annual Reports
4 Industry Magazines
5 Industry Reports
6 Credible Paid Databases
7 WHO Reports & Data
8 American Clinical Laboratory Association
9 American Hospital Association
10 Centers for Disease Control and Prevention
11 Food and Drug Administration
12 American Cancer Society

12. 12
© TechSci Research
Phase 3: TechSci Research performed periodical checks on data being collected through surveys with logic checks and analyze
survey results in MS Excel/SPSS and data generated through its proprietary database.
TechSci Research also used data triangulation technique to fill the gaps and to present the more meaningful picture of the
market. In order to forecast the United States diagnostics market, TechSci Research used various forecast techniques such as:
 Moving Average
 Time Series Analysis
 Regression analysis
 Econometric and Judgmental Analysis
TechSci Research also used its own forecasting tool, which is based on the growth of various allied industries. TechSci also
used impact analysis during short, medium and long term to estimate the demand and to reach to an accurate market
numbers.
Phase 4: TechSci Research prepared the final comprehensive project report in detailed PowerPoint Presentation format along
with the supporting documents.
Research Methodology

13. 13
© TechSci Research
Industry Brief
According to TechSci Research report, “United States Diagnostics Market By Product Type (Reagents, Instruments, Software & Services), By Type of Test (Infectious Disease Testing, Lipid Panel,
Metabolic Panel, Others), By Technique (Immunodiagnostics, Clinical Techniques, Molecular Diagnostics, Tissue Diagnostics, Others), By Usability (Reusable v/s Disposable), By Application
(Infectious Diseases (Human Papillomavirus, Hepatitis, Tuberculosis, Hospital-Acquired Infections, COVID-19), Cancer (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Liver Cancer,
Others), Sexually Transmitted Diseases (Chlamydia Trachomatis Infection, Gonorrhoea, Syphilis, Others), Others), By End User (Hospitals, Public labs, Diagnostic Centers, Point-of-Care Testing
Centers, Private or Commercial Laboratories, Others), By Region, Forecast & Opportunities, 2026”, the United States diagnostics market stood at USD30.08billion in 2020 and is expected to grow at
a steady rate of 5.17% during the forecast period on account of the changing lifestyle and dietary habits of the people. This has led to an increase in the prevalence of diseases such as cancer,
diabetes, asthma, cardiovascular diseases, renal disorders, hypertension, among others. Statistics show that every year more than 1.5 million people die because of these diseases in the country.
This has increased the demand for diagnostics in the country so that such diseases could be detected early, and the patients can get appropriate treatment. Additionally, growing number of
accredited laboratories, point-of-care testing centers, hospitals, among others is expected to further fuel the market growth. Furthermore, increasing penetration of health insurance providers is
expected to create lucrative opportunities for the market growth. However, dearth of skilled professionals in the laboratories might hamper the market growth through 2026. Additionally, need for high
complexity testing centers might further restrict the market growth over the next few years. Also, high cost of tests and budget constraints might further hinder the market growth during the forecast
period.
The United States diagnostics market is segmented based on product type, type of test, technique, usability, application, end user, company and region. Based on type of test, the market can be
segmented into infectious disease testing, lipid panel test, metabolic panel test and others. The infectious disease testing segment is expected to dominate the market in 2020 with a share of around
43.35% and will continue maintaining its dominance over the forecast period. A drastic increase in market share was observed in 2020 owing to the sudden outbreak and spread of COVID-19 in the
country which significantly increased the testing. Additionally, United States witnesses prevalence of several other infectious diseases such as human papillomavirus, hepatitis, among others. Lipid
panel tests are expected to witness significant growth during the forecast period owing to the increasing prevalence of cardiovascular diseases in the country. Based on technique, the market can be
categorized into immunodiagnostics, clinical techniques, molecular diagnostics, tissue diagnostics and others. The immunodiagnostics technique held the highest market share and will continue
maintaining its dominance over the forecast period owing to the widespread use of immunodiagnostic technique in infectious disease testing and identification of microbes, such as fungus, bacteria,
and viruses, by detection of their toxins. Additionally, increasing prevalence of chronic diseases, such as HIV, and the introduction of instruments with higher accuracy are further expected to drive
the market growth. While the tissue diagnostics and molecular diagnostics segments are expected to witness growth in the coming years owing to the increasing prevalence of different types of
cancers across United States. Based on application, the market can be fragmented into infectious diseases, cancer, sexually transmitted diseases and others. The infectious disease segment
dominated the market in 2020 and is expected to maintain its dominance over the forecast period owing to the prevalence of various infectious diseases in the United States. The spread of COVID-
19 significantly increased the segmental shares in 2020. The cancer segment is expected to witness significant growth through 2026 owing to the increase in prevalence of various kinds of cancers in
the country. Also, sexually transmitted diseases are expected to grow significantly in the future and witness growth, especially Chlamydia Trachomatis infection and Gonorrhoea.
Abbott Laboratories, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson & Johnson, Ortho-Clinical Diagnostics, Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc.,
Roche Diagnostics Corporation, Siemens Medical Solutions USA, Inc., Biomerieux Inc. and others are some of the leading players operating in United States diagnostics market. The companies
operating in the market are using organic strategies such as product launches, mergers and collaborations to boost their share. Cell-DYN Sapphire, CELL-DYN Ruby and CELL-DYN Emerald 22 AL
are hematology analyzers developed by Abbott Laboratories, Inc. and the company has launched coronavirus tests which require m2000 Real Time PCR system. The emergence of COVID-19 led to
the development of COVID-19 testing kits and PCR devices for diagnosis. For instance, the Bio-Rad Laboratories developed Platelia SARS-CoV-2 Total Ab Assay, which detects the total anti-
nucleocapsid antibodies against coronavirus SARS-CoV-2 in 2020. The company also formulated Coronavirus Ag Rapid Test Cassette (Swab) and BioPlex 2200 SARA-CoV-2 IgG Panel.
“United States diagnostics market is expected to witness steady growth during the forecast period on account of the increasing demand for personalized medicines and companion diagnostics.
Additionally, technological advancements in the healthcare industry with the advent of AI, cloud computing, IoT, among others, is further expected to propel the market growth through 2026.
Additionally, presence of major pharmaceutical & biotechnology giants in the country is further expected to create lucrative opportunities for the market growth over the next few years.” said Mr.
Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

14. 14
© TechSci Research
Sample Data - Snapshot
United States Diagnostics Market Size, By Value (USD Billion), 2016-2026F
2016 2017 2018 2019 2020 2021E 2022F 2023F 2024F 2025F 2026F
Value (USD Billion)
CAGR 2016-2020
By Value: xx%
CAGR 2021E-2026F
By Value: xx%
United States Diagnostics Market Share, By Product Type, By Value, 2016-2026F
2016 2017 2018 2019 2020 2021E 2022F 2023F 2024F 2025F 2026F
Reagents 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00%
Instruments 30.00% 30.00% 30.00% 30.00% 30.00% 30.00% 30.00% 30.00% 30.00% 30.00% 30.00%
Software & Services 50.00% 50.00% 50.00% 50.00% 50.00% 50.00% 50.00% 50.00% 50.00% 50.00% 50.00%
United States Infectious Disease Testing Market Share, By Technique, By Value, 2016-2026F
2016 2017 2018 2019 2020 2021E 2022F 2023F 2024F 2025F 2026F
Immunodiagnostics 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00%
Clinical Techniques 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00%
Molecular Diagnostics 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00%
Tissue Diagnostics 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00%
Others 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00%

15. 15
© TechSci Research
Report Ordering
Report Name: United States Diagnostics Market
Forecast and Opportunities
2016 – 2026
To View Sample OR Purchase Report
License Type Price
Single User License $3500
Multi-User License $4500
Custom Research License $7500

16. About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in
number of areas to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality
analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and global
company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.
Related Reports
• Global Diagnostic Electrocardiograph Market By Product Type (Resting ECG Devices, Stress ECG Devices, Holter Monitors, Others), By Channel
(12-channel, 6-channel, 5- channel, 3- channel, Single- channel), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Cardiac Care
Centers, Others), By Region, Competition Forecast & Opportunities, 2026
• Global Diagnostic Imaging Market By Product Type ( Architecture (Open/Closed), By Field Strength (High and Very-High Field MRI Systems), By
Systems (Ultrasound Systems, Nuclear Imaging Systems, X-Ray Imaging Systems, CT Scanner, MRI System, Mammography System, Fluoroscopy),
By Portability (Stationary, Portability), By Application (OB/Gyn, Orthopaedic, Musculosekeletal, Neuro &Spine, General Imaging, Cardio &Thoracic,
Breast health, Others), By End Users (Hospitals, Diagnostic Imaging Centers, Others), By Region, Forecast & Opportunities, 2016-2026F
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely,
accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it
considers reliable and first hand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible
for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the
subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this
document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior
approval of TechSci Research.
TechSci Research – North America
708 Third Avenue, Manhattan,
New York, United States
Tel: +1- 646- 360- 1656
Email: sales@techsciresearch.com
www.techsciresearch.com
Disclaimer
TechSci Research – Europe
54, Old brook, Bretton,
Peterborough,
United Kingdom
Email: sales@techsciresearch.com
www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital
Region, U.P. - India
Tel: +91-120-4523900
Email: sales@techsciresearch.com
www.techsciresearch.com